Synapse - Works

Results (2683)

Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma

Meeting Abstract

Drappatz, J.; Norden, A. D.; Wong, E. T.; Lassman, A. B.; Doherty, L.; LaFrankie, D.; Gerard, M.; Phan, P.; Schiff, D.; Wen, P. Y.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer

Meeting Abstract

Feilchenfeldt, J. W.; Capanu, M.; Farooki, A.; Sully, D.; Miron, B.; Power, D. G.; Jhawer, M.; Ilson, D. H.; Kelsen, D. P.; Shah, M. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer

Meeting Abstract

Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma

Meeting Abstract

Caces, D. D.; Halaas, J.; Hamlin, P.; Noy, A.; Kewalramani, T.; Portlock, C. S.; Zelenetz, A. D.; O'Connor, O. A.; Gerecitano, J. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Quality of life (QOL) with sunitinib versus interferon-alfa (IFN-α) as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): Final results

Meeting Abstract

Cella, D.; Michaelson, M. D.; Cappelleri, J. C.; Bushmakin, A. G.; Charbonneau, C.; Kim, S. T.; Li, J. Z.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)

Meeting Abstract

Conlin, A. K.; Hudis, C. A.; Bach, A.; Moynahan, M.; Lake, D.; Forero-Torres, A.; Wright, G.; Hackney, M.; Clawson, A.; Seidman, A. D.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto)

Meeting Abstract

Danila, D. C.; de Bono, J.; Ryan, C. J.; Denmeade, S.; Smith, M.; Taplin, M.; Bubley, G.; Molina, A.; Haqq, C.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer

Meeting Abstract

Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT

Meeting Abstract

Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Patterns of care and outcomes in patients with intracranial hemangiopericytomas: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Meeting Abstract

Dankwah-Quansah, M. A.; Gutin, P.; Bilsky, M.; Huse, J.; Rosenblum, M.; Abrey, L. E.; DeAngelis, L.; Omuro, A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save